Evidence map›Paper›PMID 29937706›Full record

ArticleAdvanced synthesis & catalysis2018

Chemoenzymatic Approaches to the Synthesis of the Calcimimetic Agent Cinacalcet Employing Transaminases and Ketoreductases.

Lisa Marx, Nicolás Ríos-Lombardía, Judith F Farnberger, Wolfgang Kroutil, Ana I Benítez-Mateos, Fernando López-Gallego, Francisco Morís, Javier González-Sabín, Per Berglund

Open access · hybridAbstract read
In one paragraph

Article in Advanced synthesis & catalysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Lisa MarxKTH Royal Institute of Technology Department of Industrial Biotechnology SE-106 91 Stockholm Sweden.
Nicolás Ríos-LombardíaEntreChem, S.L. Vivero Ciencias de la Salud Santo Domingo de Guzmán 33011 Oviedo Spain.
Judith F FarnbergerAustrian Centre of Industrial Biotechnology ACIB GmbH c/o University of Graz Harrachgasse 21 8010 Graz Austria.
Wolfgang KroutilInstitute of Chemistry Organic and Bioorganic Chemistry University of Graz Harrachgasse 21 8010 Graz Austria.
Ana I Benítez-MateosHeterogeneous biocatalysis group CIC biomaGUNE Edificio Empresarial "C" Paseo de Miramón 182 20009 Donostia Spain.
Fernando López-GallegoHeterogeneous biocatalysis group CIC biomaGUNE Edificio Empresarial "C" Paseo de Miramón 182 20009 Donostia Spain.
Francisco MorísEntreChem, S.L. Vivero Ciencias de la Salud Santo Domingo de Guzmán 33011 Oviedo Spain.
Javier González-SabínEntreChem, S.L. Vivero Ciencias de la Salud Santo Domingo de Guzmán 33011 Oviedo Spain.
Per BerglundKTH Royal Institute of Technology Department of Industrial Biotechnology SE-106 91 Stockholm Sweden.
EntreChem (Spain) · ESCIC biomaGUNE · ESGraz University of Technology · ATKTH Royal Institute of Technology · SEUniversity of Graz · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several chemoenzymatic routes have been explored for the preparation of cinacalcet, a calcimimetic agent. Transaminases (TAs) and ketoreductases (KREDs) turned out to be useful biocatalysts for the preparation of key optically active precursors. Thus, the asymmetric amination of 1-acetonaphthone yielded an enantiopure (

Indexed as

Asymmetric synthesisBiocatalysisCinacalcetKetoreductasesTransaminases

Identifiers

PMID29937706
PMCPMC6001662
OpenAlexW2792734982

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.